Total Raised

$41.26M

Investors Count

20

Deal Terms

2

Funding, Valuation & Revenue

9 Fundings

Muse has raised $41.26M over 9 rounds.

Muse's latest funding round was a Series C for $9.5M on August 8, 2022.

Muse's 2018 revenue was $5M. Muse's most recent revenue is from 2018.

Sign up for a free demo to see revenue data from 2018 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/8/2022

Series C

$9.5M

$XXM

0

FY undefined

7

2/13/2018

Series B - III

$XXM

$XXM

$5M

FY 2018

10

11/7/2017

Series B - II

$XXM

$XXM

$X.XXB

((X.XXx))

FY XXXX

10

10/11/2016

Convertible Note

$XXM

$XXM

0

FY undefined

10

4/24/2015

Series B

$XXM

$XXM

0

FY undefined

10

Date

8/8/2022

2/13/2018

11/7/2017

10/11/2016

4/24/2015

Round

Series C

Series B - III

Series B - II

Convertible Note

Series B

Amount

$9.5M

$XXM

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

$5M

FY 2018

$X.XXB

((X.XXx))

FY XXXX

0

FY undefined

0

FY undefined

Sources

7

10

10

10

10

Start free trial
New call-to-action

Muse Deal Terms

2 Deal Terms

Muse's deal structure is available for 2 funding rounds, including their Series B from April 24, 2015.

Round

Series B

Series A

Funding Date

$XXM

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

Board Voting

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

Muse Investors

20 Investors

Muse has 20 investors. Export Development Canada invested in Muse's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/7/2017

8/8/2022

2
Series B - II, Series C (2022)

Diversified Financial Services

Canada

8/8/2022

8/8/2022

1
Series C

Venture Capital

New Hampshire

8/8/2022

8/8/2022

1
Series C

Corporation

Minnesota

00/00/0000

00/00/0000

The Clavis Foundation

Subscribe to see more

Non-Profit Foundation

California

00/00/0000

00/00/0000

Phyto Partners

Subscribe to see more

Venture Capital

Florida

First funding

11/7/2017

8/8/2022

8/8/2022

00/00/0000

00/00/0000

Last Funding

8/8/2022

8/8/2022

8/8/2022

00/00/0000

00/00/0000

Investor

The Clavis Foundation

Phyto Partners

Rounds

2
Series B - II, Series C (2022)
1
Series C
1
Series C

Subscribe to see more

Subscribe to see more

Board Seats

Type

Diversified Financial Services

Venture Capital

Corporation

Non-Profit Foundation

Venture Capital

Location

Canada

New Hampshire

Minnesota

California

Florida

Muse Acquisitions

1 Acquisition

Muse acquired 1 company. Their latest acquisition was Meditation Studio on July 10, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/10/2018

Other

$XXM

$0.2M

Acquired

2

Date

7/10/2018

Investment Stage

Other

Companies

Valuation

$XXM

Total Funding

$0.2M

Note

Acquired

Sources

2

New call-to-action

Compare Muse to Competitors

Neurable Logo
Neurable

Neurable specializes in brain-computer interface (BCI) technology within the neurotechnology sector. The company offers products that allow users to interact with devices using brain signals. Neurable's technology can be integrated into various applications, including wellness and diagnostics. It was founded in 2015 and is based in Boston, Massachusetts.

NeuroSky Logo
NeuroSky

NeuroSky develops wearable biosensors and brainwave technology within the health and wellness sector. The company provides EEG and ECG biosensors that capture real-time brainwave and cardiac data for health monitoring, research, and product development. NeuroSky's products serve educational institutions, corporate entities, and original equipment manufacturers (OEMs) that integrate biosensor technology into their products. It was founded in 2004 and is based in San Jose, California.

IDUN Technologies Logo
IDUN Technologies

IDUN Technologies is a neurotechnology company specializing in brain-computer interfaces and EEG measurement devices. Their main offerings include in-ear EEG measurement tools and a brain analytics platform that provides real-time neuromarker data for various applications such as sleep monitoring and cognitive workload assessment. It was founded in 2017 and is based in Glattpark, Switzerland.

H
HeartMath

HeartMath is a company focused on emotional physiology and workplace performance within the health and wellness sector. They offer products and services that utilize heart rate variability technology. HeartMath serves individuals, healthcare professionals, corporate clients, and educational institutions. It was founded in 1991 and is based in Boulder Creek, California.

Calm Logo
Calm

Calm is a mental wellness brand that offers a mobile application providing guided meditations, sleep stories, and soundscapes. These resources aim to assist users in managing stress and anxiety, and improving sleep quality through mindfulness and relaxation techniques. It was founded in 2012 and is based in San Francisco, California.

DERMING SRL Logo
DERMING SRL

DERMING SRL is a dermatological research laboratory operating in the clinical testing sector for cosmetics, textiles, pharmaceuticals, and products intended for contact with skin, hair, nails, or external mucous membranes. The company conducts clinical evaluations on the tolerability and efficacy of products through dermatological examinations and develops protocols for clients. DERMING SRL serves the cosmetics and pharmaceutical industries with research and testing services. It is based in Italy.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.